Error: Could not add to watchlist. X
+ Watchlist

Actelion Ltd

ATLN:VX
Ticker Change
ATLN:VX has changed to a new ticker symbol
CHF
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (CHF) (TTM)
-
Market Cap (CHF)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.09%
% Price Change
-0.13%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Actelion Ltd is a biopharmaceutical company focused on the discovery, development and commercialization of drugs for diseases with significant unmet medical needs. The Company focuses in the field of pulmonary arterial hypertension (PAH) with treatments for diseases from WHO Functional Class (FC) II through to FC IV, with oral, inhaled and intravenous medications.
Address
Gewerbestrasse 16
Allschwil, 4123
Switzerland
Phone
41-61-565-65-65
  • Jean-Paul Clozel
    CEO/Co-Founder
  • Andre C Muller
    Exec VP/CFO
  • Otto Schwarz
    Exec VP/COO
  • Nicholas Franco
    Exec VP/Chief Bus Dev Officer
  • Guy Braunstein
    Exec VP/Head:Clinical Dev
Show More